PT Kalbe Farma Tbk.
Symbole: PTKFY
PNK
17.03
USDPrix du marché aujourd'hui
0.0056
Ratio P/E
0.0000
Ratio PEG
3.94B
Cap MRK
- 0.03%
Rendement DIV
PT Kalbe Farma Tbk. (PTKFY) États financiers
Bilan
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 3397916.9 | 263.9 | 455.6 | |||||
balance-sheet.row.short-term-investments | 0 | 165496.3 | 9.4 | 18.2 | |||||
balance-sheet.row.net-receivables | 0 | 5628331.7 | 308.5 | 249.4 | |||||
balance-sheet.row.inventory | 0 | 6791979.8 | 460 | 363.3 | |||||
balance-sheet.row.other-current-assets | 0 | 99495.7 | 44.4 | 37.2 | |||||
balance-sheet.row.total-current-assets | 0 | 15917724.1 | 1076.8 | 1105.6 | |||||
balance-sheet.row.property-plant-equipment-net | 0 | 8537934.7 | 535.8 | 586.3 | |||||
balance-sheet.row.goodwill | 0 | 479347.4 | 30.9 | 14.8 | |||||
balance-sheet.row.intangible-assets | 0 | 1327234.2 | 1066868.8 | 961154.4 | |||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1806581.6 | 1546216.2 | 1170837.9 | |||||
balance-sheet.row.long-term-investments | 0 | 285302.3 | 24.8 | 21.3 | |||||
balance-sheet.row.tax-assets | 0 | 136102.6 | 8.2 | 6.5 | |||||
balance-sheet.row.other-non-current-assets | 0 | 373922.8 | -1546106.4 | -1170751.6 | |||||
balance-sheet.row.total-non-current-assets | 0 | 11139844.1 | 678.6 | 700.4 | |||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-assets | 0 | 27057568.2 | 1755.4 | 1806 | |||||
balance-sheet.row.account-payables | 0 | 1690719.6 | 128.7 | 117.3 | |||||
balance-sheet.row.short-term-debt | 0 | 299759.4 | 55.1 | 6.6 | |||||
balance-sheet.row.tax-payables | 0 | 225196.6 | 13.8 | 19 | |||||
balance-sheet.row.long-term-debt-total | 0 | 318778.9 | 18.5 | 34.5 | |||||
Deferred Revenue Non Current | 0 | 0 | 1.6 | 3 | |||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||
balance-sheet.row.other-current-liab | 0 | 1252689.5 | 87.9 | 105.7 | |||||
balance-sheet.row.total-non-current-liabilities | 0 | 694377.6 | 45.9 | 60.9 | |||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.capital-lease-obligations | 0 | 41907.5 | 1.6 | 3 | |||||
balance-sheet.row.total-liab | 0 | 3937546.2 | 331.5 | 309.7 | |||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.common-stock | 0 | 468751.2 | 30.2 | 33 | |||||
balance-sheet.row.retained-earnings | 0 | 21162752.5 | 1300.8 | 1299.5 | |||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 53.5 | 49.4 | 47.7 | |||||
balance-sheet.row.other-total-stockholders-equity | 0 | -212700.7 | -66.9 | -2.5 | |||||
balance-sheet.row.total-stockholders-equity | 0 | 21418856.5 | 1313.6 | 1377.7 | |||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 27057568.2 | 1755.4 | 1806 | |||||
balance-sheet.row.minority-interest | 0 | 1701165.5 | 110.3 | 118.7 | |||||
balance-sheet.row.total-equity | 0 | 23120022 | 1423.9 | 1496.3 | |||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||
Total Investments | 0 | 450798.6 | 34.1 | 39.6 | |||||
balance-sheet.row.total-debt | 0 | 618538.4 | 75.2 | 44.1 | |||||
balance-sheet.row.net-debt | 0 | -2613882.2 | -179.3 | -393.3 |
Tableau des flux de trésorerie
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 181.1 | 228.4 | 222.4 | |||||
cash-flows.row.depreciation-and-amortization | 0 | 47.9 | 49.4 | 47.1 | |||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||
cash-flows.row.change-in-working-capital | 0 | 0 | 0 | 0 | |||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | |||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | |||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | |||||
cash-flows.row.other-working-capital | 0 | 0 | 0 | 0 | |||||
cash-flows.row.other-non-cash-items | 0 | -35.9 | -191.1 | -68.6 | |||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -1178972.2 | -58.8 | -69.9 | |||||
cash-flows.row.acquisitions-net | 0 | 63609.6 | -44.9 | 82.8 | |||||
cash-flows.row.purchases-of-investments | 0 | -173704.2 | -8.6 | -17.5 | |||||
cash-flows.row.sales-maturities-of-investments | 0 | 4.7 | 16.7 | 8.5 | |||||
cash-flows.row.other-investing-activites | 0 | 148275.5 | -0.3 | 0 | |||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -1140786.7 | -95.9 | 3.8 | |||||
cash-flows.row.debt-repayment | 0 | -2513595.4 | -24.2 | -35.4 | |||||
cash-flows.row.common-stock-issued | 0 | 0 | -2.6 | 0 | |||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -67.7 | 0 | |||||
cash-flows.row.dividends-paid | 0 | -1757714.4 | -110.2 | -91.7 | |||||
cash-flows.row.other-financing-activites | 0 | 35572 | 44.6 | -6 | |||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -2443986.3 | -160 | -133.1 | |||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -40050.4 | 237776.4 | -16432.5 | |||||
cash-flows.row.net-change-in-cash | 0 | -717348.3 | -182.9 | 65.7 | |||||
cash-flows.row.cash-at-end-of-period | 0 | 3232420.6 | 254.5 | 437.4 | |||||
cash-flows.row.cash-at-beginning-of-period | 0 | 3949768.9 | 437.4 | 371.7 | |||||
cash-flows.row.operating-cash-flow | 0 | 193.1 | 86.8 | 200.9 | |||||
cash-flows.row.capital-expenditure | 0 | -1178972.2 | -58.8 | -69.9 | |||||
cash-flows.row.free-cash-flow | 0 | -1178779.2 | 28 | 131 |
Row du compte de résultat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 30449134.1 | 1953.9 | 1834.5 | |||||
income-statement-row.row.cost-of-revenue | 0 | 18625888.5 | 1189.7 | 1073.3 | |||||
income-statement-row.row.gross-profit | 0 | 11823245.5 | 764.2 | 761.2 | |||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||
income-statement-row.row.research-development | 0 | - | - | - | |||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.other-expenses | 0 | -6.3 | -15 | -15.6 | |||||
income-statement-row.row.operating-expenses | 0 | 8198108.5 | 481.4 | 483.3 | |||||
income-statement-row.row.cost-and-expenses | 0 | 26823997 | 1671.1 | 1556.5 | |||||
income-statement-row.row.interest-income | 0 | 88217.6 | 5.5 | 7.7 | |||||
income-statement-row.row.interest-expense | 0 | 82958.2 | 3.7 | 4 | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.total-other-income-expensenet | 0 | -66015.4 | 18.3 | 11.5 | |||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||
income-statement-row.row.other-operating-expenses | 0 | -6.3 | -15 | -15.6 | |||||
income-statement-row.row.total-operating-expenses | 0 | -66015.4 | 18.3 | 11.5 | |||||
income-statement-row.row.interest-expense | 0 | 82958.2 | 3.7 | 4 | |||||
income-statement-row.row.depreciation-and-amortization | 0 | 333650.2 | 49.4 | 47.1 | |||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||
income-statement-row.row.operating-income | 0 | 3672252.6 | 282.8 | 277.9 | |||||
income-statement-row.row.income-before-tax | 0 | 3606237.2 | 301.1 | 289.4 | |||||
income-statement-row.row.income-tax-expense | 0 | 827832.4 | 68.1 | 63.7 | |||||
income-statement-row.row.net-income | 0 | 2766748 | 228.4 | 222.4 |
Questions fréquemment posées
Quel est le total de PT Kalbe Farma Tbk. (PTKFY) de l'actif total?
PT Kalbe Farma Tbk. (PTKFY) Le total des actifs est 27057568182323.000.
Quel est le revenu annuel de l'entreprise?
Le revenu annuel est N/A.
Quelle est la marge bénéficiaire de l'entreprise?
La marge bénéficiaire de l'entreprise est 0.370.
Quel est le flux de trésorerie disponible de l'entreprise?
Le flux de trésorerie disponible est -1793.009.
Quelle est la marge bénéficiaire nette de l'entreprise?
La marge bénéficiaire nette est 0.089.
Quel est le revenu total de l'entreprise?
Le revenu total est 0.123.
Qu'est-ce que PT Kalbe Farma Tbk. (PTKFY) bénéfice net (revenu net)?
Le bénéfice net (revenu net) est 2766748040055.000.
Quel est l'endettement total de l'entreprise?
La dette totale est 618538351178.000.
Quel est le montant des dépenses d'exploitation?
Les dépenses d'exploitation sont 8198108504360.000.
Quel est le montant de la trésorerie de l'entreprise?
Les liquidités de l'entreprise sont 0.000.